We are pleased to share that Karyopharm has been recognized as a 2025 Top Workplaces USA award winner by USA TODAY! This is a testament to our culture and our people that work hard for our patients every day. #TopWorkplaces #BelieversInTheExtraordinary #BelieversInOurPeople
关于我们
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL).
- 网站
-
https://www.karyopharm.com
Karyopharm Therapeutics Inc.的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Newton,MA
- 类型
- 上市公司
- 领域
- oncology、pharmaceutical、biotech、multiplemyeloma、lymphoma、solidtumors、clinicalresearch、clinicaltrials、research、drugdiscovery、medical和healthcare
地点
-
主要
85 Wells Avenue
US,MA,Newton,02459
Karyopharm Therapeutics Inc.员工
动态
-
Attention US HCPs: Karyopharm strives to provide accurate and timely medical information, the latest congress and publications information to our US HCPs about our products and disease areas of interest. If you want more information visit the Karyopharm Global Medical and Scientific Affairs Website that has been developed to keep you abreast of our latest research. #MultipleMyeloma #Myelofibrosis #EndometrialCancer #BelieversInTheExtraordinary
The Karyopharm Medical Affairs team is proud to present our Medical Affairs website that provides the latest updates, medical resources and education to support US healthcare professionals in advancing patient care. Find out more from our SVP of Global Medical and Scientific Affairs Amama Sadiq MD, MPH, and visit the Karyopharm Medical Affairs website here: https://lnkd.in/et6fCthG #BelieversinScience #KPTI
-
On #InternationalWomensDay, we would like to shine a spotlight on?Jenny Myers Ahlstrom, a #multiplemyeloma patient who was determined to harness the collective power of patient experiences to help people with blood cancer learn more about their disease and better navigate their care. In 2012, she founded the HealthTree Foundation to do just that. Learn more about this organization:?https://bit.ly/41grx53?#BelieversInTheExtraordinary
-
-
March is Multiple Myeloma Action Month! This year's theme, #MyelomaMilestone, is empowering individuals to share their personal milestones in the fight against #multiplemyeloma. We're proud to partner with the?International Myeloma Foundation?in its mission to amplify patient voices. Learn more about this initiative:?https://bit.ly/3XwjAHU
-
-
Congratulations to our 2025 Q1 ICARE award winners who exemplify our company values: Innovation, Courage, Alignment & Accountability, and Energy.??Karyopharm's ICARE values drive our mission to pioneer novel cancer treatment and improve patient outcomes.?We are committed to fostering a culture of collaboration and excellence, empowering our teams to challenge the status quo and deliver groundbreaking therapies.?Cynthia Brasher Bhargavi Pandit RPh, MS, RAC Kai Li, Ph.D in Statistics Danielle Miller Christine E. Lentowski M.S. M.B.A. #EmployeeAppreciationDay
-
-
Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress. Learn more here: https://bit.ly/3Qmlo2b
-
Introducing our new Talent Community! Not ready to apply? Not seeing a job that matches your interests? Join our Talent Community to stay connected.?By signing up, you’ll gain access to updates about career opportunities, company news, and information tailored to your professional interests. Whether you are exploring future roles or simply would like to stay informed, our Talent Community keeps you informed and inspired. Connect with us today! https://lnkd.in/ezb6h6dT
-
-
Karyopharm to report fourth quarter and full year 2024 financial results and recent company progress on Wednesday, February 19. Tune in to the webcast at 8 A.M. ET. Learn more here: https://bit.ly/3CVHQvK
-
We're proud to support the?Union for International Cancer Control (UICC)?in its #WorldCancerDay campaign, #UnitedByUnique, which highlights the importance of people-centered approaches to?cancer?and the unique needs of each patient. Learn more about this initiative and the UICC:?https://bit.ly/40V8qi3?#BelieversInTheExtraordinary
-